T cell involvement in cutaneous drug eruptions

Clinical and Experimental Allergy

Volumn 31, Issue 9, 2001, Pages 1398-1408

  Hari, Y ^a   Frutig Schnyder, K ^a   Hurni, M ^a   Yawalkar, N ^a   Zanni, M P ^a   Schnyder, B ^a   Kappeler, A ^a   Von Greyerz, S ^a   Braathen, L R ^a   Pichler, W J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cytotoxicity; Drug allergy; Exanthema; T cells

Indexed keywords

ACETAZOLAMIDE; ALLOPURINOL; AMOXICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BECOZYM; BENZALKONIUM CHLORIDE; CARBAMAZEPINE; CEFAZOLIN; CEFTRIAXONE; CILASTATIN; CITALOPRAM; COTRIMOXAZOLE; DORZOLAMIDE; IMIPENEM; INDAPAMIDE; LOSARTAN; METOLAZONE; METRONIDAZOLE; PENICILLIN G; PREDNISOLONE; SIMVASTATIN; THIAMINE; THIORIDAZINE; TICLOPIDINE; TOBRAMYCIN; TORASEMIDE; UNINDEXED DRUG; VERAPAMIL; VITAMIN B COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SPECIFICITY; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; MALE; PATCH TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SKIN BIOPSY; T LYMPHOCYTE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; CD8-POSITIVE T-LYMPHOCYTES; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EXANTHEMA; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SKIN; T-LYMPHOCYTES;

EID: 0034854608     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01164.x     Document Type: Article

References (27)

1. Drug induced skin disease
2. Comprehensive hospital drug monitoring (CHDM): Adverse skin reactions, a 20-year survey
3. Urticaria and angioedema
4. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis
5. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions
6. Drug induced severe skin reactions. Incidence, management and prevention
7. Drug hypersensitivity syndrome
8. Pharmacological and immunochemical mechanisms of drug hypersensitivity
9. Heterogeneous T cell responses to lactam-modified self structures are observed in penicillin allergic individuals
10. T cell reactivity to penicillin. Phenotypic analysis of in vitro activated cell subsets
11. T cell recognition of penicillin G. Structural features determining antigenic specificity
12. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfamethoxazole, phenytoin and carbamazepine
13. Characterization of lidocaine specific T cells
14. High IL-5 production by human drug-specific T cell clones
15. Direct MHC-dependent presentation of the drug sulfamethoxazole to human αβ+ T cell clones
16. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis
17. The lymphocyte transformation test for the diagnosis of drug allergy: Sensitivity and specificity
18. The lymphocyte transformation test for diagnosis of drug-induced occupational allergy
19. Terminology of contact dermatitis
20. T-lymphocyte-antigen interactions in transplant rejection
21. Patch testing in cutaneous reactions caused by carbamazepine
22. Drug-specific T cells derived from patients with drug-induced allergic hepatitis
23. Predominance of epidermal CD8+ T lymphocytes with bullous cutaneous reactions caused by beta-lactam antibiotics
24. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cells clones
25. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human ab T lymphocytes
26. Role of T cells in drug allergies
27. T cell mediated cytotoxicity against keratinocytes in sulfamethoxazole induced skin reaction